It is important to emphasize that the samples in the study by Moresco et al. came from the southwest of the state of Amazonas, where there is a high prevalence of hepatitis B, with approximately 100% of donors from this region reactive for anti-HBc. The gene discussed is KRT88P; the disease is hepatitis B virus infection.